Your browser doesn't support javascript.
loading
Targeted proteomics improves cardiovascular risk prediction in secondary prevention.
Nurmohamed, Nick S; Belo Pereira, João P; Hoogeveen, Renate M; Kroon, Jeffrey; Kraaijenhof, Jordan M; Waissi, Farahnaz; Timmerman, Nathalie; Bom, Michiel J; Hoefer, Imo E; Knaapen, Paul; Catapano, Alberico L; Koenig, Wolfgang; de Kleijn, Dominique; Visseren, Frank L J; Levin, Evgeni; Stroes, Erik S G.
Afiliação
  • Nurmohamed NS; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Belo Pereira JP; Department of Cardiology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Hoogeveen RM; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Kroon J; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Kraaijenhof JM; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Waissi F; Department of Vascular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
  • Timmerman N; Department of Vascular Surgery, Division of Surgical Specialties, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Bom MJ; Department of Vascular Surgery, Division of Surgical Specialties, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Hoefer IE; Department of Cardiology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Knaapen P; Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Catapano AL; Department of Cardiology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Koenig W; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milano, Italy.
  • de Kleijn D; IRCCS Multimedica, Milano, Italy.
  • Visseren FLJ; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Levin E; German Centre for Cardiovascular Research (DZHK e.V.), Partner Site Munich Heart Alliance, Munich, Germany.
  • Stroes ESG; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
Eur Heart J ; 43(16): 1569-1577, 2022 04 19.
Article em En | MEDLINE | ID: mdl-35139537

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Isquemia Encefálica / Acidente Vascular Cerebral / Aterosclerose Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Isquemia Encefálica / Acidente Vascular Cerebral / Aterosclerose Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2022 Tipo de documento: Article